Clinical Trials

Phase I study of single-agent and combined checkpoint inhibition after allogeneic hematopoietic stem cell transplantation in patients at high risk for post-transplant recurrence


Study ID
HackensackUMC CPIT Trial 002

NCT Number
NCT02846376 (Click on the NCT number for more information about the trial)

Research Study Number
2016-0526

Principle Investigator
Dr. James McCloskey

Phase
I

Sponsor
HackensackUMC


Other protocol defined inclusion/exclusion criteria could apply If you are a physician and would like more details about this study, please contact us at JTCCResearch@HackensackMeridian.org

Apply Now